Market revenue in 2022 | USD 1,162.0 million |
Market revenue in 2030 | USD 1,069.7 million |
Growth rate | -1% (CAGR from 2022 to 2030) |
Largest segment | Hiv |
Fastest growing segment | Herpes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | HIV, Hepatitis, Herpes, Influenza |
Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 34.42% in 2022. Horizon Databook has segmented the South Korea antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
The South Korea antiviral drugs market is anticipated to grow owing to increasing healthcare expenditure, favorable government initiatives, and the high burden of viral infectious diseases. Moreover, the expansion of drug manufacturing by several market players fuels the growth of the country’s market.
For instance, in May 2022, Hyundai Bioscience announced the launch of CP-COV03 Phase 2 clinical trials, an oral antiviral drug developed for treating several viral diseases, including COVID-19. Moreover, a number of drug manufacturers are focusing on gaining approval to manufacture and sell their products in South Korea. For instance, in January 2023, Shionogi, a Japanese drug maker, applied for approval to manufacture and sell its COVID-19 pill for treatment overseas.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into South Korea antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account